Table 13 Ranks of resistance rates in China, U.S. and Kuwait, 2001(Rank correlations at bottom of table)
From: Antibiotic resistance as a global threat: Evidence from China, Kuwait and the United States
| Bacterium(a) | Antibiotic(s) | China | U.S. | Kuwait |
|---|---|---|---|---|
| SAU | Methicillin | 3 | 2 | 11 |
| SPN | Erythromycin | 1 | 4 | 4 |
| Cefotaxime | 21 | 5 | 14 | |
| Enterococcus spp | Vancomycin | 20 | 7 | 17 |
| ECO | Ceftazidime | 15 | 17 | 13 |
| Cefotaxime | 8 | 18 | 15 | |
| Ceftriaxone | 6 | 19 | 16 | |
| Ciprofloxacin/Ofloxacin | 2 | 13 | 3 | |
| PAE | Ceftazidime | 11 | 8 | 2 |
| Ciprofloxacin/Ofloxacin | 5 | 3 | 1 | |
| KPN | Ceftazidime | 16 | 9 | 7 |
| Cefotaxime | 12 | 10 | 8 | |
| Ceftriaxone | 7 | 11 | 9 | |
| Ciprofloxacin | 9 | 6 | 6 | |
| Salmonella spp | Amoxicillin-clavulanate | 13 | 12 | 12 |
| Ceftriaxone | 19 | 20 | 18 | |
| Ciprofloxacin | 22 | 21 | 10 | |
| TMP/SMX | 23 | 14 | 19 | |
| Gentamicin | 14 | 15 | 20 | |
| Shigella spp | Amoxicillin-clavulanate | 4 | 16 | 5 |
| Ceftriaxone | 17 | 23 | 21 | |
| Ciprofloxacin | 18 | 24 | 22 | |
| TMP/SMX | 24 | 1 | 23 | |
| Gentamicin | 10 | 22 | 24 | |
| Correlation Coefficients | CHN_US: 0.18 | US_KW: 0.46 | CHN_KW: 0.60 | |